BARD1 and neoplasm: Similarly, pathogenic variants in the highly conserved BRCT domains, which typically facilitate recruitment of the BRCA1-BARD1 complex to sites of DNA damage, impair DNA repair activity and disrupt tumor-suppressive function [53,54].